triamcinolone has been researched along with Ureteral Obstruction in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Edelblute, BT; Gupta, M; Katims, AB; Mehrazin, R; Tam, AW; Zampini, AM | 1 |
| Felsen, D; Gross, SS; Kim, FY; Marion, D; Schulsinger, D; Vaughan, ED | 1 |
| Clayman, RV; Elbahnasy, AM; Hoenig, DM; McDougall, EM; Shalhav, AL; Smith, D | 1 |
3 other study(ies) available for triamcinolone and Ureteral Obstruction
| Article | Year |
|---|---|
Long-Term Outcomes of Laser Incision and Triamcinolone Injection for the Management of Ureteroenteric Anastomotic Strictures.
Topics: Anastomosis, Surgical; Constriction, Pathologic; Cystectomy; Follow-Up Studies; Humans; Lasers; Postoperative Complications; Retrospective Studies; Treatment Outcome; Triamcinolone; Ureteral Obstruction; Urinary Diversion | 2021 |
Renal hemodynamic and ureteral pressure changes in response to ureteral obstruction: the role of nitric oxide.
Topics: Animals; Dogs; Enzyme Inhibitors; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; omega-N-Methylarginine; Pressure; Renal Circulation; Triamcinolone; Ureter; Ureteral Obstruction; Vasodilator Agents | 2003 |
Impact of etiology of secondary ureteropelvic junction obstruction on outcome of endopyelotomy.
Topics: Adult; Aged; Aged, 80 and over; Endoscopy; Glucocorticoids; Humans; Kidney; Kidney Pelvis; Middle Aged; Nephrostomy, Percutaneous; Pain, Postoperative; Radionuclide Imaging; Retreatment; Retrospective Studies; Stents; Treatment Outcome; Triamcinolone; Ureteral Obstruction | 1998 |